{"transactions":[{"id":924403,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-02-02T21:04:42.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":5.71,"value":1313300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 30, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":230000,"derivative":{"exercise_price":5.71,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001939167-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000193916726000002/primarydocument.xml","form_type":"4"}},{"id":1295291,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-24T21:13:52.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":4.37,"value":502550.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":115000,"derivative":{"exercise_price":4.37,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001562180-25-000504","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218025000504/primarydocument.xml","form_type":"4"}},{"id":1399855,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-24T20:01:55.000Z","date":"2024-09-23","kind":"exercise","planned":true,"acquired":false,"shares":857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested."}],"balance_after":39789,"derivative":{"exercise_price":3.72,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":857},"source":{"system":"sec-edgar","filing":"0001562180-24-006927","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006927/primarydocument.xml","form_type":"4"}},{"id":1399854,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-24T20:01:55.000Z","date":"2024-09-20","kind":"exercise","planned":true,"acquired":false,"shares":35756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested."}],"balance_after":40646,"derivative":{"exercise_price":3.72,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":35756},"source":{"system":"sec-edgar","filing":"0001562180-24-006927","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006927/primarydocument.xml","form_type":"4"}},{"id":1399853,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-24T20:01:55.000Z","date":"2024-09-23","kind":"sale","planned":true,"acquired":false,"shares":857,"price":10.17,"value":8715.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-24-006927","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006927/primarydocument.xml","form_type":"4"}},{"id":1399852,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-24T20:01:55.000Z","date":"2024-09-23","kind":"exercise","planned":true,"acquired":true,"shares":857,"price":3.72,"value":3188.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."}],"balance_after":857,"source":{"system":"sec-edgar","filing":"0001562180-24-006927","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006927/primarydocument.xml","form_type":"4"}},{"id":1399851,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-24T20:01:55.000Z","date":"2024-09-20","kind":"sale","planned":true,"acquired":false,"shares":35756,"price":10.04,"value":358990.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.22 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-24-006927","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006927/primarydocument.xml","form_type":"4"}},{"id":1399850,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-24T20:01:55.000Z","date":"2024-09-20","kind":"exercise","planned":true,"acquired":true,"shares":35756,"price":3.72,"value":133012.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."}],"balance_after":35756,"source":{"system":"sec-edgar","filing":"0001562180-24-006927","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006927/primarydocument.xml","form_type":"4"}},{"id":1401341,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-20T20:00:59.000Z","date":"2024-09-18","kind":"exercise","planned":true,"acquired":false,"shares":11574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested."}],"balance_after":76402,"derivative":{"exercise_price":3.72,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":11574},"source":{"system":"sec-edgar","filing":"0001562180-24-006885","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006885/primarydocument.xml","form_type":"4"}},{"id":1401340,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-20T20:00:59.000Z","date":"2024-09-18","kind":"sale","planned":true,"acquired":false,"shares":11574,"price":10.05,"value":116318.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.25 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-24-006885","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006885/primarydocument.xml","form_type":"4"}},{"id":1401339,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-20T20:00:59.000Z","date":"2024-09-18","kind":"exercise","planned":true,"acquired":true,"shares":11574,"price":3.72,"value":43055.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."}],"balance_after":11574,"source":{"system":"sec-edgar","filing":"0001562180-24-006885","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006885/primarydocument.xml","form_type":"4"}},{"id":1403079,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T20:01:22.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":false,"shares":10272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested."}],"balance_after":87976,"derivative":{"exercise_price":3.72,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":10272},"source":{"system":"sec-edgar","filing":"0001562180-24-006859","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006859/primarydocument.xml","form_type":"4"}},{"id":1403078,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T20:01:22.000Z","date":"2024-09-16","kind":"exercise","planned":true,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested."}],"balance_after":98248,"derivative":{"exercise_price":3.72,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001562180-24-006859","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006859/primarydocument.xml","form_type":"4"}},{"id":1403077,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-18T20:01:22.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":10272,"price":10.04,"value":103130.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.18 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-24-006859","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006859/primarydocument.xml","form_type":"4"}},{"id":1403076,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-18T20:01:22.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":true,"shares":10272,"price":3.72,"value":38211.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."}],"balance_after":10272,"source":{"system":"sec-edgar","filing":"0001562180-24-006859","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006859/primarydocument.xml","form_type":"4"}},{"id":1403075,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-18T20:01:22.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":400,"price":10,"value":4000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-24-006859","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006859/primarydocument.xml","form_type":"4"}},{"id":1403074,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2024-09-18T20:01:22.000Z","date":"2024-09-16","kind":"exercise","planned":true,"acquired":true,"shares":400,"price":3.72,"value":1488.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001562180-24-006859","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024006859/primarydocument.xml","form_type":"4"}},{"id":1670623,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-25T21:03:02.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":3.06,"value":275400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":90000,"derivative":{"exercise_price":3.06,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001562180-24-000607","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218024000607/primarydocument.xml","form_type":"4"}},{"id":2041764,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-30T22:03:27.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":65000,"derivative":{"exercise_price":8.38,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-23-000725","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218023000725/primarydocument.xml","form_type":"4"}},{"id":2195106,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68155,"kind":"person","name":"Costa Carlos","position":1,"cik":"0001939167","reported_name":"Costa Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-04T01:06:24.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the underlying shares of common stock on August 1, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested."}],"balance_after":50000,"derivative":{"exercise_price":14.2,"expiration_date":"2032-07-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001562180-22-005891","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822462/000156218022005891/primarydocument.xml","form_type":"4"}}]}